W J Nooijen

Insulin resistance and breast‐cancer risk

Peter F. Bruning, Johannes M.G. Bonfrèr, P.A.H. van Noord et al. · International Journal of Cancer · 1992 · 360 citations

Insulin Resistance, Metabolic Syndrome, Breast Oncology +13

Nonlinear pharmacokinetics of paclitaxel in mice results from the pharmaceutical vehicle Cremophor EL.

Alex Sparreboom, Olaf van Tellingen, W J Nooijen et al. · PubMed · 1996 · 315 citations

Nonlinear Pharmacokinetics, Medicinal Chemistry, Pharmaceutical Science +14

Enhanced oral bioavailability of paclitaxel in mice treated with the P-glycoprotein blocker SDZ PSC 833

Judith van Asperen, Olaf van Tellingen, Alex Sparreboom et al. · British Journal of Cancer · 1997 · 202 citations · Full text

Molecular Pharmacology, Medicine, Experimental Pharmacology +6

Altered Pharmacokinetics of Vinblastine in Mdr1a P-glycoprotein-Deficient Mice

Judith van Asperen, Alfred H. Schinkel, Jos H. Beijnen et al. · JNCI Journal of the National Cancer Institute · 1996 · 176 citations

Increased oral bioavailability of paclitaxel by GF120918 in mice through selective modulation of P-glycoprotein.

Heleen A. Bardelmeijer, Jos H. Beijnen, Kenneth R. Brouwer et al. · PubMed · 2000 · 121 citations

Molecular Pharmacology, Tumor Biology, Oral Bioavailability +15